Print
Email
This is an example where smaller investors who aren’t going to move the market can get make a good return with low risk. If you find a few of these each year, you’ll be in good shape. If you’re thinking about buying in and tendering your shares, read the filing here. There are a few things you need to know: The tender date may be extended, the percentage necessary to be tendered may not be met, the deal could fall apart due to the government or a legal ruling, and some negative info on its Hepatitis C drug could come out. I don’t think any of that will happen over the next ten days, but you should at least be aware of the risk.
I bought into Inhibitex a few weeks ago because I thought the spread was too great compared to the risk of the deal not going through. The spread at the time of my purchase was more than 7%. Considering the stock has traded between $2.15 and the $26 offer price, there is a good reason that there is a decent size spread. Plus, the company is dependent on one drug, so any bad news associated with it would be a serious problem. That’s why I made it a small position.
At this point, though, with eight days to go, that little bit of risk is now very close to zero. Don’t forget to factor in the short-term capital gains rate and any tender fees your custodian may charge.
Learn more at Intellectual Honesty.
Disclosure: Long INHX
Subscribe RSS
Steven,
I've read the TO and other 13 and 14Ds that have been proliferating on the SEC website. There is a lawsuit (not class action) and a request for an injunction against this tender - which will have a preliminary hearing on Monday, Feb 6th. What are your thoughts on the requested injunction?